Junyong Park
Overview
Explore the profile of Junyong Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cho D, Shim Y, Jung J, Nam S, Min S, Lee S, et al.
Adv Sci (Weinh)
. 2020 Jun;
7(11):1903708.
PMID: 32537413
The realization of high-contrast modulation in optically transparent media is of great significance for emerging mechano-responsive smart windows. However, no study has provided fundamental strategies for maximizing light scattering during...
12.
Cho J, Park J, Tae G, Jin M, Kwon I
Biomedicines
. 2020 May;
8(5).
PMID: 32357510
Conjugation of serum albumin or one of its ligands (such as fatty acid) has been an effective strategy to prolong the serum half-lives of drugs via neonatal Fc receptor (FcRn)-mediated...
13.
Bak M, Park J, Min K, Cho J, Seong J, Hahn Y, et al.
Pharmaceutics
. 2020 Apr;
12(4).
PMID: 32316169
The number of therapeutic peptides for human treatment is growing rapidly. However, their development faces two major issues: the poor yield of large peptides from conventional solid-phase synthesis, and the...
14.
Cho J, Park J, Kim S, Kim J, Tae G, Jin M, et al.
J Control Release
. 2020 Feb;
321:49-58.
PMID: 32006589
Therapeutic proteins are indispensable for treatment of various human diseases. However, intrinsic short serum half-lives of proteins are still big hurdles for developing new therapeutic proteins or expanding applications of...
15.
Wang D, Park J, Patil S, Smith C, Leazer Jr J, Keire D, et al.
J Pharm Sci
. 2020 Jan;
109(4):1519-1528.
PMID: 31927041
Protein or peptide higher order structure (HOS) is a quality attribute that could affect therapeutic efficacy and safety. Where appropriate, the HOS similarity between a proposed follow-on product and the...
16.
Jeon S, Song E, Lee D, Park J, Nam Y, Kim J, et al.
Aging Dis
. 2019 Aug;
10(2):307-328.
PMID: 31435482
Alzheimer's disease (AD), which is the most major cause of dementia, is a progressive neurodegenerative disease that affects cognitive functions. Even though the prevalence of AD is continuously increasing, few...
17.
Jeon S, Hong S, Nam Y, Tae J, Yoo A, Song E, et al.
Ageing Res Rev
. 2019 Aug;
55:100945.
PMID: 31434007
Ghrelin, which has many important physiological roles, such as stimulating food intake, regulating energy homeostasis, and releasing insulin, has recently been studied for its roles in a diverse range of...
18.
Kim S, Kim M, Jung S, Kwon K, Park J, Kim S, et al.
J Control Release
. 2019 Jul;
309:181-189.
PMID: 31356840
Therapeutic proteins are indispensable in the treatment of various human diseases. Despite the many benefits of therapeutic proteins, they also exhibit diverse side effects. Therefore, reducing unwanted side effects of...
19.
Lee K, Yoon H, Ahn C, Park J, Jeon S
Nanoscale
. 2019 Mar;
11(15):7025-7040.
PMID: 30920558
TiO2-based photocatalysis has been considered to be one of the most promising avenues for environmental remediation including water purification. However, several technical issues such as the limited surface area of...
20.
Park J, Doyle P
Langmuir
. 2018 Nov;
34(48):14643-14651.
PMID: 30400737
Hierarchical assembly of heterogeneous particles is of great importance to interface and colloid science. In this work, a facile but powerful approach for the large-scale production of multifunctional hydrogel particles...